Patient experience data in regulatory decisions: Questions abound in first FDA report
The FDA on Tuesday released its first report on the use of patient experience data in approval decisions, although it makes clear there’s a lot …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
